Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tandem Diabetes Care (TNDM) Assets Average (2016 - 2025)

Historic Assets Average for Tandem Diabetes Care (TNDM) over the last 12 years, with Q3 2025 value amounting to $875.2 million.

  • Tandem Diabetes Care's Assets Average fell 764.25% to $875.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $875.2 million, marking a year-over-year decrease of 764.25%. This contributed to the annual value of $960.2 million for FY2024, which is 424.48% down from last year.
  • Tandem Diabetes Care's Assets Average amounted to $875.2 million in Q3 2025, which was down 764.25% from $898.9 million recorded in Q2 2025.
  • In the past 5 years, Tandem Diabetes Care's Assets Average registered a high of $1.1 billion during Q4 2022, and its lowest value of $735.3 million during Q1 2021.
  • For the 5-year period, Tandem Diabetes Care's Assets Average averaged around $928.8 million, with its median value being $946.3 million (2023).
  • As far as peak fluctuations go, Tandem Diabetes Care's Assets Average soared by 11969.03% in 2021, and later tumbled by 989.08% in 2023.
  • Quarter analysis of 5 years shows Tandem Diabetes Care's Assets Average stood at $877.7 million in 2021, then grew by 19.65% to $1.1 billion in 2022, then decreased by 9.89% to $946.3 million in 2023, then increased by 1.73% to $962.7 million in 2024, then dropped by 9.09% to $875.2 million in 2025.
  • Its Assets Average stands at $875.2 million for Q3 2025, versus $898.9 million for Q2 2025 and $944.9 million for Q1 2025.